Acuta Capital Partners, LLC Lannett CO Inc Put Options Transaction History

Acuta Capital Partners, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $2.54 Million - $3.73 Million	-127,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $1.93 Million - $2.45 Million	127,500	127,500 $2.35 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.